14,500 Shares in Enhabit, Inc. (NYSE:EHAB) Purchased by OLD National Bancorp IN
14,500 Shares in Enhabit, Inc. (NYSE:EHAB) Purchased by OLD National Bancorp IN
OLD National Bancorp IN purchased a new position in shares of Enhabit, Inc. (NYSE:EHAB – Get Rating) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 14,500 shares of the company's stock, valued at approximately $204,000.
根據Old National Bancorp IN最近提交給美國證券交易委員會的13F文件，該公司在第三季度購買了EnHabit，Inc.(紐約證券交易所代碼：EHAB-GET Rating)的新股票頭寸。該基金購買了14,500股該公司股票，價值約204,000美元。
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Retirement Systems of Alabama acquired a new position in Enhabit during the third quarter worth about $982,000. Landscape Capital Management L.L.C. acquired a new position in Enhabit during the third quarter worth about $220,000. Foster & Motley Inc. acquired a new position in Enhabit during the third quarter worth about $153,000. Maryland State Retirement & Pension System acquired a new position in Enhabit during the third quarter worth about $340,000. Finally, BCR Wealth Strategies LLC purchased a new position in Enhabit during the third quarter worth about $78,000. 95.55% of the stock is currently owned by institutional investors and hedge funds.
其他機構投資者和對衝基金最近也買賣了該公司的股票。阿拉巴馬州退休系統公司在第三季度收購了EnHabit的一個新頭寸，價值約98.2萬美元。景觀資本管理公司在第三季度收購了EnHabit的一個新頭寸，價值約22萬美元。Foster&Motley Inc.在第三季度收購了EnHabit的一個新頭寸，價值約15.3萬美元。馬裏蘭州退休和養老金系統在第三季度在EnHabit獲得了一個新的職位，價值約34萬美元。最後，BCR Wealth Strategy LLC在第三季度購買了EnHabit的一個新頭寸，價值約7.8萬美元。95.55%的股票目前由機構投資者和對衝基金持有。
Enhabit Trading Down 5.7 %
安居降價5.7%
Shares of EHAB stock opened at $15.10 on Monday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.50 and a current ratio of 1.50. The company has a 50 day moving average price of $13.87 and a 200 day moving average price of $14.25. Enhabit, Inc. has a fifty-two week low of $11.65 and a fifty-two week high of $25.25.
週一，Ehab的股票開盤報15.10美元。該公司的負債權益比為0.63，速動比率為1.50，流動比率為1.50。該公司的50日移動均線價格為13.87美元，200日移動均線價格為14.25美元。EnHabit，Inc.的股價為52周低點11.65美元，52周高點25.25美元。
Insider Activity at Enhabit
EnHabit的內幕活動
Analyst Upgrades and Downgrades
分析師升級和下調評級
EHAB has been the topic of a number of analyst reports. UBS Group initiated coverage on shares of Enhabit in a research note on Thursday, December 8th. They set a "sell" rating and a $12.00 target price on the stock. CJS Securities began coverage on shares of Enhabit in a research note on Tuesday, December 13th. They set a "market perform" rating and a $18.00 target price on the stock. Oppenheimer began coverage on shares of Enhabit in a research note on Thursday, October 13th. They issued a "market perform" rating on the stock. Stifel Nicolaus began coverage on shares of Enhabit in a research note on Monday, December 5th. They issued a "buy" rating and a $17.00 price target on the stock. Finally, Credit Suisse Group reduced their price target on shares of Enhabit from $19.00 to $15.00 and set a "neutral" rating on the stock in a research note on Friday, November 4th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $16.43.
埃哈布一直是許多分析師報告的主題。瑞銀集團在12月8日星期四的一份研究報告中啟動了對EnHabit股票的報道。他們為該股設定了“賣出”評級和12.00美元的目標價。CJS證券於12月13日(星期二)在一份研究報告中開始報道EnHabit的股票。他們為該股設定了“市場表現”評級和18.00美元的目標價。奧本海默於10月13日星期四在一份研究報告中開始報道EnHabit的股票。他們對該股給予了“市場表現”的評級。Stifel Nicolaus於12月5日星期一在一份研究報告中開始報道EnHabit的股票。他們對該股給予了“買入”評級和17.00美元的目標價。最後，瑞士信貸集團在11月4日(星期五)的一份研究報告中將EnHabit的股票目標價從19.00美元下調至15.00美元，並將其股票評級定為“中性”。兩名股票研究分析師對該股的評級為賣出，四名分析師給出了持有評級，兩名分析師給出了該公司的買入評級。根據MarketBeat.com，該股目前的普遍評級為持有，平均目標價為16.43美元。
Enhabit Company Profile
安居公司簡介
(Get Rating)
(獲取評級)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
EnHabit，Inc.在美國提供家庭健康和臨終關懷服務。它的家庭健康服務包括患者教育、疼痛管理、傷口護理和換藥、心臟康復、輸液治療、藥物管理和熟練的觀察和評估服務；治療慢性疾病和狀況的做法，包括糖尿病、高血壓、關節炎、阿爾茨海默病、低視力、椎管狹窄、帕金森病、骨質疏鬆症、複雜傷口護理和慢性疼痛，以及針對糖尿病、充血性心力衰竭、骨科術後手術或損傷和呼吸系統疾病的特定疾病計劃；以及物理、職業和語言治療師提供治療服務。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Enhabit (EHAB)
- Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
- MarketBeat Week in Review – 1/30 – 2/3
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- 免費獲取StockNews.com關於EnHabit的研究報告(Ehab)
- C3.ai人工智能產品套件是遊戲變革者嗎？
- 市場回顧周-1/30-2/3
- 細價股值得嗎？你應該投資細價股嗎？
- Zimmer Biomet盈利節節攀升，增長可能被計入價格
- 人工智能軟件製造商EPAM號稱科技板塊漲幅最大
Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB – Get Rating).
想看看其他對衝基金持有埃哈布的股份嗎？訪問HoldingsChannel.com獲取EnHabit，Inc.(紐約證券交易所代碼：EHAB-GET Rating)的最新13F備案和內幕交易信息。
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
接受《居住者日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對EnHabit和相關公司的最新新聞和分析師評級的每日簡要摘要。